This Week: New Batch of Data Boosts Spravato’s Case Analysis: Bipartisan Breakthrough Therapies Act Berkeley Health Commission Votes to Move Psychedelics Decrim. Resolution to City Council Master’s Student Finds Flaw in LSD-Induced Neural Entropy Study; Leads to Retraction VA Publishes Evidence Review of Psychedelics DEA Increases Aggregate Production Quotas and lots more… New Batch of Data Boosts…


Previous articlePsychedelic Research Bulletin: November 2022
Next articlePT376 – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits